Correction of Hypercoagulation in Pregnant Women, by Using Intermittent Plasmapheresis in Combination with 10% HES
Objective: to evaluate the impact of intermittent plasmapheresis in combination with 10% HES (Refortan® HES 10%, Berlin-Chemie AG) on hemostatic parameters in pregnant women with hypercoagulation syndrome. Subjects and methods. One hundred and forty pregnant women at 25-to-34 weeks gestational age w...
Main Authors: | T. A. Fedorova, O. V. Rogachevsky, A. S. Ochan |
---|---|
Format: | Article |
Language: | English |
Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2009-12-01
|
Series: | Общая реаниматология |
Online Access: | https://www.reanimatology.com/rmt/article/view/526 |
Similar Items
-
PLASMAPHERESIS IN COMPLEX TREATMENT OF PREGNANT WOMEN WITH ACUTE APPENDICITIS
by: N. F. Khvorostukhina, et al.
Published: (2016-06-01) -
Use of plasmapheresis and intravenous immunoglobulins in pregnant women with antiphospholipid syndrome
by: Ekaterina Sergeevna Orlova, et al.
Published: (2019-08-01) -
Use of plasmapheresis in women with placenta isufficiency after IVF
by: F B Buranova, et al.
Published: (2010-06-01) -
Plasmapheresis in the ICU
by: Guleid Hussein, et al.
Published: (2023-12-01) -
Hypercoagulability and thrombosis
by: Maria Domenica Cappellini, et al.
Published: (2013-03-01)